Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
On Rare Disease Day, CSL brought together a team of volunteers who pedaled during daylight hours to generate energy needed fo…
CSL joined the Global Chain of Lights to light up the night on February 29 to acknowledge the millions who live with rare dis…
EURORDIS, which represents rare disease patients in Europe, celebrates advocates who distinguish themselves in categories inc…
A new survey of more than 1,000 U.S. residents finds that few know how common rare diseases are, but 85% said it was importan…
Few Australians understand how common rare diseases are, but 89% said it was important to research innovative new treatments,…
This February 29, we bring our collective focus to the cause and demonstrate the power of showing our stripes, says therapist…
We asked the leaders of patient advocacy groups – and CSL staff – to explain why rare conditions deserve attention and recogn…
Rare Disease Day on February 29 offers a chance to show solidarity with the estimated 300 million people living with rare dis…
Eurordis, the European patient advocacy group, invites people around the world to take a photo that “visually expresses what …
The global celebration unites rare disease patients and their advocates on February 29. Find out how to show your support.
Get a look behind the scenes to learn how CSL Behring in Germany found a green way to light up a local landmark for Rare Dise…
In Marburg, Germany, CSL Behring employees wanted to light up a local landmark to celebrate Rare Disease Day. But to be respo…
Americas
Asia Pacific
Middle East
Europe
